Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: A randomized controlled trial

Archives of Dermatology

Volumn 147, Issue 8, 2011, Pages 926-930

  Senet, Patricia ^a   Vicaut, Eric ^b   Beneton, Nathalie ^c   Debure, Clelia ^d   Lok, Catherine ^e   Chosidow, Olivier ^f,g  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c Centre Hospitalier General   (France)

^d Paris Descartes University   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; REGRANEX GEL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HYDROGEL DRESSING; HYPERTENSIVE LEG ULCER; INTERMETHOD COMPARISON; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WOUND CLOSURE;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LEG ULCER; MALE; PLATELET-DERIVED GROWTH FACTOR;

EID: 80051685663     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.84     Document Type: Article

References (23)

1. Hines EA Jr, Farber EM. Ulcer of the leg due to arteriolosclerosis and ischemia, occurring in the presence of hypertensive disease (hypertensive- ischemic ulcers). Mayo Clin Proc. 1946;21(18):337-346.
2. Lazareth I, Priollet P. Necrotic angiodermatitis: treatment by early cutaneous grafts [in French]. Ann Dermatol Venereol. 1995;122(9):575-578. (Pubitemid 26018682)
3. Dagregorio G, Guillet G. A retrospective review of 20 hypertensive leg ulcers treated with mesh Skin grafts. J Eur Acad Dermatol Venereol. 2006;20(2):166-169. (Pubitemid 43740516)
4. Schnier BR, Sheps SG, Juergens JL. Hypertensive ischemic ulcer: a review of 40 cases. Am J Cardiol. 1966;17(4):560-565.
5. Henderson CA, Highet AS, Lane SA, Hall R. Arterial hypertension causing leg ulcers. Clin Exp Dermatol. 1995;20(2):107-114.
6. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens. 2001;15(4):279-283. (Pubitemid 32293687)
7. Davidson S, Lee E, Newton ED. Martorell's ulcer revisited. Wounds. 2003;15(6):208-212. (Pubitemid 36793532)
8. Vuerstaek JD, Reeder SW, Henquet CJ, Neumann HA. Arteriolosclerotic ulcer of Martorell. J Eur Acad Dermatol Venereol. 2010;24(8):867-874.
9. Leu HJ. Hypertensive ischemic leg ulcer (Martorell's ulcer): a specific disease entity? Int Angiol. 1992;11(2):132-136.
10. Shutler SD, Baragwanath P, Harding KG. Martorell's ulcer. Postgrad Med J. 1995; 71(842):717-719. (Pubitemid 26004038)
11. Hafner J, Nobbe S, Partsch H, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol. 2010;146 (9):961-968.
12. Duncan HJ, Faris IB. Martorell's hypertensive ischemic leg ulcers are secondary to an increase in the local vascular resistance. J Vasc Surg. 1985;2(4):581-584. (Pubitemid 15239013)
13. Chaby G, Senet P, Vaneau M, et al. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol. 2007;143(10):1297-1304. (Pubitemid 47607683)
14. El Khatib K, Danino A, Rzin A, Malka G. Necrotic angiodermatitis: evaluation of an early skin graft treatment. Ann Chir Plast Esthet. 2009;54(6):567-570.
15. Woolling KR. Hypertensive ischemic ulcer: an atypical ischemic necrosis of the skin. JAMA. 1964;187(3):196-201.
16. Kirsner RS, Falanga V, Eaglstein WH. The biology of skin grafts: skin grafts as pharmacologic agents. Arch Dermatol. 1993;129(4):481-483. (Pubitemid 23118247)
17. Enoch S, Grey JE, Harding KG. Recent advances and emerging treatments. BMJ. 2006;332(7547):962-965.
18. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983-1992.
19. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127(12):2726-2739. (Pubitemid 350134835)
20. Kantor J, Margolis DJ. Efficacy and prognostic value of simple wound measurements. Arch Dermatol. 1998;134(12):1571-1574. (Pubitemid 29009258)
21. Whitehead J, ed. The Design and Analysis of Sequential Clinical Trials. 2nd ed. Chichester, England: Ellis Horwood; 1992.
22. D'Hemecourt P, Smiell JM, Karim MR. Sodium carboxymethyl cellulose aqueousbased gel vs. becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. Wounds. 1998;10(3):69-75.
23. Hernández-Cañete C, Betancourt BY. Management of a hypertensive ulcer with an epidermal growth factor-based formulation. J Wound Care. 2008;17(9):380-382.